Jefferies Group LLC:企業の戦略・SWOT・財務分析

◆英語タイトル:Jefferies Group LLC - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4301
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Jefferies Group LLC – Strategy, SWOT and Corporate Finance Report
Summary

Jefferies Group LLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Jefferies Group LLC (JGL), a subsidiary of Jefferies Financial Group Inc, is a financial services company that offers investment banking, sales and trading, and wealth management solutions. Investment banking includes equity and debt capital market solutions, financial advisory, mergers and acquisitions, restructuring, and recapitalization services. The company conducts sales and trading activities across equities, fixed income and foreign exchange products. It manages a wide range of alternative asset management platforms across an array of asset classes and investment strategies. The company also provides services such as research and strategy, corporate lending and real estate finance, prime brokerage, and equity finance. It has presence in Asia, Europe, and Americas. JGL is headquartered in New York, the US.

Scope

- Detailed information on Jefferies Group LLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Jefferies Group LLC in the form of a SWOT analysis
- An in-depth view of the business model of Jefferies Group LLC including a breakdown and examination of key business segments
- Intelligence on Jefferies Group LLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Jefferies Group LLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Jefferies Group LLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Jefferies Group LLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Jefferies Group LLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Jefferies Group LLC: Company Overview
Jefferies Group LLC: Overview and Key Facts
Jefferies Group LLC: Overview
Jefferies Group LLC: Key Facts
Jefferies Group LLC: Key Employees
Jefferies Group LLC: Key Employee Biographies
Jefferies Group LLC: Major Products and Services
Jefferies Group LLC: Company History
Jefferies Group LLC: Management Statement
Jefferies Group LLC: Locations and Subsidiaries
Jefferies Group LLC: Key Competitors
Jefferies Group LLC: Company Analysis
Jefferies Group LLC: Business Description
Jefferies Group LLC: SWOT Analysis
Jefferies Group LLC: SWOT Overview
Jefferies Group LLC: Strengths
Jefferies Group LLC: Weaknesses
Jefferies Group LLC: Opportunities
Jefferies Group LLC: Threats
Jefferies Group LLC: Corporate Financial Deals Activity
Jefferies Group LLC: Financial Deals Overview
Jefferies Group LLC: Targets and Partners
Jefferies Group LLC: Top Deals 2016 – 2020YTD*
Jefferies Group LLC: Advisors
Jefferies Group LLC: Top Legal Advisors
Jefferies Group LLC: Top Financial Advisors
Jefferies Group LLC: Corporate Venturing
Jefferies Group LLC: Capital Raising
Jefferies Group LLC: Recent Developments
Jefferies Group LLC: News and Events Summary
Jefferies Group LLC: Business Expansion
Jefferies Group LLC: Business Reorganization
Jefferies Group LLC: Contracts
Jefferies Group LLC: Corporate Governance
Jefferies Group LLC: Financial Deals
Jefferies Group LLC: Financial Performance
Jefferies Group LLC: Market Developments
Jefferies Group LLC: Red Flags/DistressSignals
Jefferies Group LLC: Regulatory and Legal Events
Jefferies Group LLC: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Jefferies Group LLC: Key Facts
Table 2: Jefferies Group LLC: Key Employees
Table 3: Jefferies Group LLC: Company History
Table 4: Jefferies Group LLC: Locations and Subsidiaries
Table 5: Jefferies Group LLC: Key Competitors
Table 6: Jefferies Group LLC: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Jefferies Group LLC: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Jefferies Group LLC: Targets and Partners
Table 9: Jefferies Group LLC: Top Deals 2016 - 2020YTD*
Table 10: Jefferies Group LLC: Legal Advisor Ranking by Value (US$m)
Table 11: Jefferies Group LLC: Financial Advisor Ranking by Value (US$m)
Table 12: Jefferies Group LLC: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 13: Jefferies Group LLC: Corporate Venturing by Geography (2016 - YTD*2020)
Table 14: Jefferies Group LLC: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 15: Jefferies Group LLC: Capital Raising by Deal Type (2016 - YTD*2020)
Table 16: Jefferies Group LLC: News and Events Summary
Table 17: Jefferies Group LLC: Business Expansion
Table 18: Jefferies Group LLC: Business Reorganization
Table 19: Jefferies Group LLC: Contracts
Table 20: Jefferies Group LLC: Corporate Governance
Table 21: Jefferies Group LLC: Financial Deals
Table 22: Jefferies Group LLC: Financial Performance
Table 23: Jefferies Group LLC: Market Developments
Table 24: Jefferies Group LLC: Red Flags/DistressSignals
Table 25: Jefferies Group LLC: Regulatory and Legal Events
Table 26: Jefferies Group LLC: Strategy and Operations

★海外企業調査レポート[Jefferies Group LLC:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Progenics Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Progenics Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Progenics Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Immatics Biotechnologies GmbH:企業の戦略的SWOT分析
    Immatics Biotechnologies GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Repligen Corp (RGEN):企業の財務・戦略的SWOT分析
    Summary Repligen Corp (Repligen) is a bioprocessing life science company that develops and commercializes consumable products for manufacturing biological drugs. The company's products include Protein A affinity resins, Protein A ligands, ELISA kits, alternating tangential flow system, OPUS pre pack …
  • Bulova Technologies Group, Inc.:戦略・SWOT・企業財務分析
    Bulova Technologies Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bulova Technologies Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Peregrine Pharmaceuticals Inc (PPHM)-製薬・医療分野:企業M&A・提携分析
    Summary Peregrine Pharmaceuticals Inc (Peregrine) is a biopharmaceutical company that develops and manufactures monoclonal antibodies for the treatment and diagnosis of cancer. The company’s products include Bavituximab, PGN650 and Cotara. Its Bavituximab is a monoclonal antibody that binds to a bas …
  • The Boston Beer Co Inc (SAM):企業の財務・戦略的SWOT分析
    The Boston Beer Co Inc (SAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Pasteur Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Pasteur Institute is a non-profit foundation that provides research, health services and teaching services. The foundation conducts research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structura …
  • Bonavista Energy Corp (BNP):企業の財務・戦略的SWOT分析
    Bonavista Energy Corp (BNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Public Power Corporation SA (PPC):企業の財務・戦略的SWOT分析
    Public Power Corporation SA (PPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Environics Oy:企業の戦略・SWOT・財務情報
    Environics Oy - Strategy, SWOT and Corporate Finance Report Summary Environics Oy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • University Health Network:製薬・医療:M&Aディール及び事業提携情報
    Summary University Health Network (UHN) is a health care institution that provides patient care, research and educational services, and patient support services. It offers health care services such as palliative care, pharmacy and telehealth. UHN also provides specialized program services, accessibi …
  • Power Mech Projects Ltd (POWERMECH):企業の財務・戦略的SWOT分析
    Power Mech Projects Ltd (POWERMECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DEPObank – Banca Depositaria Italiana S.p.A:企業の戦略的SWOT分析
    DEPObank - Banca Depositaria Italiana S.p.A - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • OBI Pharma Inc (4174):製薬・医療:M&Aディール及び事業提携情報
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • Myriad Genetics, Inc.:企業の戦略・SWOT・財務分析
    Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • FTI Consulting, Inc.:企業の戦略・SWOT・財務情報
    FTI Consulting, Inc. - Strategy, SWOT and Corporate Finance Report Summary FTI Consulting, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Collegium Pharmaceutical Inc (COLL)-医療機器分野:企業M&A・提携分析
    Summary Collegium Pharmaceutical Inc (Collegium) is a healthcare products provider that develops chronic pain and oral drug delivery solutions. The company's lead candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone that uses DETERx technology for the long-te …
  • Senseonics Inc:企業の戦略的SWOT分析
    Senseonics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • OncoMed Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    OncoMed Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's OncoMed Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • OUE Ltd:戦略・SWOT・企業財務分析
    OUE Ltd - Strategy, SWOT and Corporate Finance Report Summary OUE Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆